Private company
Achilles Therapeutics plc
Last updated Oct 16, 2026.
Overview
-$69.7MNet income, fiscal 20232
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023
Financial statements
No quarterly figures reported.
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Research and development | $9.1M4 | $22.6M5 | $42.2M2 | $57.3M2 | $58.2M2 | |
| Operating income | -$13.8M4 | -$33.7M5 | -$64.2M2 | -$78.4M2 | -$75.3M2 | |
| Income tax | $3.0K5 | $37.0K2 | $111.0K2 | $491.0K2 | ||
| Net income | -$14.0M4 | -$33.2M5 | -$61.1M2 | -$71.2M2 | -$69.7M2 | |
| Earnings per share | -$31.145 | -$2.132 | -$1.822 | -$1.742 | ||
| Earnings per share (diluted) | -$31.145 | -$2.132 | -$1.822 | -$1.742 |
No quarterly figures reported.
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Cash | $10.7M4 | $97.6M4 | $177.8M5 | $266.3M2 | $173.3M2 | $131.5M2 |
| Current assets | $187.8M4 | $284.7M5 | $196.6M2 | $145.6M2 | ||
| Total assets | $218.9M4 | $317.1M5 | $220.4M2 | $161.5M2 | ||
| Current liabilities | $16.6M4 | $19.1M5 | $18.0M2 | $17.0M2 | ||
| Total liabilities | $29.5M4 | $27.6M5 | $23.3M2 | $19.1M2 | ||
| Shareholders’ equity | $12.7M4 | $101.3M5 | $189.4M2 | $289.5M2 | $197.0M2 | $142.4M2 |
| Shares outstanding | 4.4M shares4 | 40.6M shares4 | 40.9M shares5 | 41.1M shares2 |
Former names
- Achilles Therapeutics LtdNov 27, 2020 to Feb 3, 20213
Recent filings
- Mar 20, 20256-K
- Feb 28, 20256-K
- Feb 4, 20256-K
- Jan 6, 20256-K
- Dec 26, 20246-K
- Dec 2, 20246-K
- Nov 14, 20246-K
- Sep 19, 20246-K
- Aug 14, 20246-K
- Aug 5, 20246-K
- Jun 27, 20246-K
- May 24, 20246-K
- May 17, 20246-K
- May 8, 20246-K
- Apr 4, 202420-F
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5